Pregnancy-Induced Hypertension: Evidence for Altered Functional Features of Platelets

References

• Fitzgerald D J, Entman S S, Mulloy K, FitzGerald G A. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75: 956–63
   PubMed Web of Science ®Google Scholar
• Greer I A, Calder A A, Walker J J, Lunan C B, Tulloch I. Increased platelet reactivity in pregnancy-induced hypertension and uncomplicated diabetic pregnancy: an indication for antiplatelet therapy. Br J Obstet Gynaecol 1988; 95: 1204–8
   PubMedGoogle Scholar
• Horn E H, Cooper J, Hardy E, Heptinstall S, Rubin P C. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Clin Sci 1991; 80: 549–58
   PubMed Web of Science ®Google Scholar
• Lewis P J, Boylan P, Friedman L A, Hensby C N, Downing I. Prostacyclin in pregnancy. Br Med J. 1980; 280: 1581–2
   PubMed Web of Science ®Google Scholar
• Ylikorkala O, Makila U M. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obstet Gynecol 1985; 152: 318–29
   PubMed Web of Science ®Google Scholar
• Walsh S W. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152: 335–40
   PubMed Web of Science ®Google Scholar
• O'Brien W F, Saba H I, Knuppel R A, Scerbo J C, Cohen G R. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1986; 155: 486–90
   PubMed Web of Science ®Google Scholar
• Burgess-Wilson M E, Morrison R, Heptinstall S. Spontaneous platelet aggregation in heparinised blood during pregnancy. Thromb Res 1986; 37: 385–93
   Google Scholar
• Wallenburg H CS. Prevention of hypertensive disorders in pregnancy. Clin Exper Hyper Pregnancy 1988; B7: 121–37
   Google Scholar
• Ylikorkala O, Kirkinen P, Viinikka L. Maternal plasma prostacyclin concentration in preeclampsia and other pregnancy complications. Br J Obstet Gynaecol 1981; 88: 968–73
   PubMedGoogle Scholar
• Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62
   PubMed Web of Science ®Google Scholar
• Wilkens D, Wilkins M H, Lunec J, Ball G, Dormandy T L. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981; 18: 158–64
   PubMedGoogle Scholar
• Halliwell B, Gutteridge J MC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1–14
   PubMed Web of Science ®Google Scholar
• Burton K P, McCord J M, Ghai G. Myocardial alterations due to free-radical generation. Am J Physiol 1984; 246: H776–83
   Google Scholar
• Cohen G. Oxidative stress in the nervous system. Oxydative stress, H Sies. Academic Press, London 1985; 383–402
   Google Scholar
• Loesser K E, Kukreja R C, Kazziha S Y, Jesse R L, Hess M L. Oxidative damage to the myocardium: a fundamental mechanism of myocardial injury. Cardioscience 1991; 2: 199–216
   PubMedGoogle Scholar
• Ishihara M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta 1978; 84: 1–9
   PubMed Web of Science ®Google Scholar
• Strata P, Canavese C, Gurioli L, Porcu M C, Garbo E, Belliardo F, Todros T, . Plasma antioxidant potential in normal pregnancy and in preeclampsia. Hypertension in Pregnancy, E V Cosmi, G C Di Renzo, et al. Monduzzi Editore, Bologna 1991; 97–103
   Google Scholar
• Massobrio M, Benedetto C, Bertini E, Fantino A, Abbondanza M, Emanuel A. Arachidonic acid derivatives in the pathophysiology of pregnancy-induced hypertension. Clin Exper Hyper Pregnancy 1988; B7: 43–55
   Google Scholar
• Gresele P, Arnout J, Coene M C, Deckmyn H, Vermylen J. Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. Biochem Biophys Res Commun 1986; 137: 334–42
   PubMed Web of Science ®Google Scholar
• Pelusi G, Scagliarini G, Biagi G, De Rosa V, Busacchi P. Whole blood production of leukotriene B4 is increased in gestational hypertension. Hypertension in pregnancy, E V Cosmi, G C Di Renzo. Monduzzi, Bologna 1991; 299–302
   Google Scholar
• Smith J B, Ingerman C M, Silver M J. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 1976; 88: 167–72
   PubMed Web of Science ®Google Scholar
• McMillan R M, MacIntyre D E, Gordon J L. Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets. Tromb Res 1977; 11: 425–8
   PubMedGoogle Scholar
• Donner M, Stoltz J F. Comparative study on fluorescent probes distibuted in human erythrocytes and platelets. Biorheology 1985; 22: 385–97
   PubMed Web of Science ®Google Scholar
• Tozzi-Ciancarelli M G, Di Giulio A, Troiani-Sevi E, D'Alfonso A, Amicosante G, Oratore A. Human erythrocyte damage at initial stage of oxidative stress. Cell Biophys 1989; 15: 225–34
   PubMedGoogle Scholar
• MacIntyre D E. Platelet prostaglandin receptors. Platelets in biology and pathology-2, J L Gordon. Elsevier/North-Holland, Amsterdam 1981; 211–47
   Google Scholar
• McKay D G. Chronic intravascular coagulation in normal pregnancy and preeclampsia. Contrib Nephrol 1981; 25: 108–15
   PubMedGoogle Scholar
• Wallenburg H CS, Rotmans N. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet Gynecol 1982; 144: 523–8
   PubMed Web of Science ®Google Scholar
• Louden K A, Broughton Pipkin F, Heptinstall S, Fox S C, Mitchell J RA, Symonds E M. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and preeclampsia. Br J Obstet Gynecol 1991; 98: 1239–44
   PubMedGoogle Scholar